Andrew Steven Johnson

Affiliations

  • Vp, Preclinical Development at Cortex Pharmaceuticals Inc (COR), 2010-02-02
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
COR $0.38 350 $133.00 0 2009-04-13 Filing
COR $0.37 200 $74.00 350 2009-04-13 Filing
COR $0.36 1,800 $648.00 550 2009-04-13 Filing